Sphingobacterium respiratory tract infection in patients with cystic fibrosis

被引:37
作者
Lambiase A. [1 ]
Rossano F. [1 ]
Del Pezzo M. [1 ]
Raia V. [2 ]
Sepe A. [2 ]
De Gregorio F. [2 ]
Catania M. [1 ]
机构
[1] Department of Cellular and Molecular Biology and Pathology luigi Califano, Medicine School, University of Naples ederico II, 80131, Naples, Pansini street
[2] Department of Pediatrics, Medicine School, University of Naples federico II, 80131, Naples, Pansini street
关键词
Cystic Fibrosis; Cystic Fibrosis Patient; Sputum Sample; Burkholderia Cepacia; Cystic Fibrosis Lung;
D O I
10.1186/1756-0500-2-262
中图分类号
学科分类号
摘要
Background. Bacteria that belong to the genus Sphingobacterium are Gram-negative, non-fermentative bacilli, ubiquitous in nature and rarely involved in human infections. The aims of this study were to evaluate the epidemiology of infection by Sphingobacterium in a cohort of patients affected by Cystic Fibrosis (CF), the antibiotic susceptibility and the DNA fingerprinting of the isolated strains and to analyze some clinical outcomes of the infected patients. Findings. Between January 2006 and June 2008, patients (n = 332) attending the Regional CF Unit in Naples, Italy, were enrolled. Sputum samples were processed for microscopic, cultural, phenotypic identification and antibiotic susceptibility testing. DNA fingerprinting was performed by pulsed-field gel electrophoresis (PFGE). A total of 21 strains of Sphingobacterium were isolated from 7 patients (13 of S. spiritovorum, 8 of S. multivorum). S. multivorum isolates were more resistant than those of S. spiritovorum. PFGE profiles were in general heterogeneous, which suggested independent circulation. Conclusions. This is the first Italian report about respiratory tract infections by Sphingobacterium in CF patients. In our cohort, these infections were not associated with a deterioration of pulmonary function during the follow-up period. Although the exact role of this microorganism in CF lung disease is unknown and the number of infected patients was small, this study could represent an important starting-point for understanding the epidemiology and the possible pathogenic role of Sphingobacterium in CF patients. © 2009 Lambiase et al.
引用
收藏
相关论文
共 23 条
  • [1] Ramsey B.W., Management of pulmonary disease in patients with cystic fibrosis, New England Journal of Medicine, 335, 3, pp. 179-188, (1996)
  • [2] Gilligan P.H., Microbiology of airway diseases in patients with cystic fibrosis, Clin Microbiol Rev, 4, pp. 35-51, (1991)
  • [3] Demko C.A., Stern R.C., Doershunk C.F., Stenotrophomonas maltophilia in cystic fibrosis: Incidence and prevalence, Pediatr Pulmonol, 25, pp. 304-308, (1998)
  • [4] Lambiase A., Raia V., Del Pezzo M., Sepe A., Carnovale V., Rossano F., Microbiology of airway disease in a cohort of patients with Cystic Fibrosis, BMC Infect Dis, 6, (2006)
  • [5] Olivier K., Yankaskas J.R., Knowles M.R., Nontuberculous mycobacterial pulmonary diseases in cystic fibrosis, Semin Respir Infect, 11, pp. 272-284, (1996)
  • [6] Vu-Thien H., Moissenet D., Valcin M., Dulot C., Tournier G., Garbarg-Chenon A., Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia and Alcaligenes xylosoxidans in a cystic fibrosis centre, Eur J Clin Microbiol Infect Dis, 15, pp. 249-260, (1996)
  • [7] Allice T., Scutera S., Chirillo M.G., Savoia D., Burkholderia respiratory tract infections in Italian patients with cystic fibrosis: Molecular characterization, J Infect, 53, pp. 159-165, (2006)
  • [8] Raso T., Bianco O., Grosso B., Zucca M., Savoia D., Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patiernts, APMIS, 118, pp. 837-841, (2008)
  • [9] Freney J., Hansen W., Ploton C., Meugnier H., Madier S., Bornstein N., Fleurette J., Septicemia caused by Sphingobacterium multivorum, J Clin Microbiol, 25, pp. 1126-1128, (1987)
  • [10] Holmes B., Owen R.J., Hollis D.G., Flavobacterium spiritovorum, a new species isolated from human clinical specimens, Int J Syst Bacteriol, 32, pp. 157-165, (1982)